BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatotic liver disease
1
Type 2 diabetes, sex and metabolic dysfunction-associated steatotic liver disease
5/11/2026 9:00:22 AM | Browse: 14 | Download: 44
2
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 134 | Download: 223
3
Steatotic liver disease in patients with chronic hepatitis C
12/26/2025 10:27:32 AM | Browse: 81 | Download: 409
4
Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
11/27/2025 7:53:58 AM | Browse: 80 | Download: 293
5
Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease
11/27/2025 7:53:53 AM | Browse: 69 | Download: 300
6
Microbiome and gut-liver interactions: From mechanisms to therapies
10/27/2025 8:08:12 AM | Browse: 242 | Download: 328
7
Impact of metabolic endoscopy on fibrosis regression in steatotic liver disease
9/25/2025 11:24:01 AM | Browse: 125 | Download: 209
8
Are we standing on the shifting sands of post-transplant metabolic-associated steatotic liver disease?
7/25/2025 12:09:47 PM | Browse: 217 | Download: 557
9
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease
7/25/2025 12:09:44 PM | Browse: 126 | Download: 575
10
Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease
4/25/2025 8:22:59 AM | Browse: 138 | Download: 476
11
Disparities in Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Associated Hepatocellular Carcinoma
4/18/2025 8:22:03 AM | Browse: 130 | Download: 624
12
Patterns of dietary supplement use among United States patients with steatotic liver disease: Vitamins, minerals and botanicals
3/26/2025 4:06:51 AM | Browse: 158 | Download: 600
13
Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis
1/6/2025 8:47:56 AM | Browse: 171 | Download: 814
14
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
1/6/2025 8:47:56 AM | Browse: 143 | Download: 559
15
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
12/30/2024 6:47:30 AM | Browse: 142 | Download: 526
16
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
11/29/2024 2:50:17 PM | Browse: 315 | Download: 919
17
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 273 | Download: 906
18
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
6/20/2024 3:42:22 AM | Browse: 288 | Download: 678
19
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
4/19/2024 3:18:01 AM | Browse: 214 | Download: 681
20
Liver biopsy in the post-hepatitis C virus era in Japan
4/12/2024 4:45:44 PM | Browse: 186 | Download: 968
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.